CAPTAIN STUDY: TREATMENT OUTCOMES FROM FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL ACCORDING TO HISTORY OF SEVERE ASTHMA EXACERBATIONS

被引：0
|
作者：
Oppenheimer, J.
Brusselle, G.
Busse, W.
Fowler, A.
Jain, N.
Mannino, D.
Pavord, I.
Win, P.
Zarankaite, A.
Kerwin, E.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P202
引用
收藏
页码：S26 / S27
页数：2
相关论文
共 50 条
  • [21] Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI in inadequately controlled asthma: the CAPTAIN study
    Pavord, Ian
    Peachey, Guy
    Kerstjens, Huib
    Kerwin, Edward
    Nathan, Robert
    Hanania, Nicola
    Pascoe, Steven
    Fowler, Andrew
    Bailes, Zelie
    Edwards, Dawn
    Sule, Neal
    Barnes, Neil
    Boulet, Louis-Philippe
    Tabberer, Maggie
    Lee, Laurie
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB241 - AB241
  • [22] Characterization of Patients with Asthma Initiating Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI)
    Wrobleski, Kristin
    Noorduyn, Stephen
    Lee, Lydia
    Igboekwe, Emmeline
    Liu, Meixia
    Veeranki, Phani
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2024, 153 (02) : AB101 - AB101
  • [23] Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) versus FF/VI in inadequately controlled asthma: the CAPTAIN study
    Pavord, Ian
    Peachey, Guy
    Kerstjens, Huib
    Kerwin, Edward
    Nathan, Robert
    Hanania, Nicola A.
    Pascoe, Steven
    Fowler, Andrew
    Bailes, Zelie
    Edwards, Dawn
    Sule, Neal
    Barnes, Neil
    Boulet, Louis-Philippe
    Tabberer, Maggie
    Lee, Laurie A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2020, 41 (06) : 459 - 460
  • [24] Patient considerations in the treatment of COPD: focus on the new combination inhaler fluticasone furoate/umeclidinium/vilanterol
    Molino, Antonio
    Calabrese, Giovanna
    Maniscalco, Mauro
    PATIENT PREFERENCE AND ADHERENCE, 2018, 12 : 993 - 1001
  • [25] Captain Study: Daily Digital Spirometry and Symptom Data for Once-Daily, Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Asthma
    Lee, L.
    Boulet, L.
    Fowler, A.
    Tabberer, M.
    Bailes, Z.
    Pascoe, S.
    Kerwin, E. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [26] Pharmacodynamic and pharmacokinetic assessment of fluticasone furoate plus vilanterol for the treatment of asthma
    Calzetta, Luigino
    Rinaldi, Barbara
    Cazzola, Mario
    Matera, Maria Gabriella
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (07) : 813 - 822
  • [27] InforMing the PAthway of COPD Treatment (IMPACT Trial) Single-Inhaler Triple Therapy (Fluticasone Furoate/Umeclidinium/Vilanterol) Versus Fluticasone Furoate/Vilanterol and Umeclidinium/Vilanterol in Patients With COPD: Analysis o the Western Europe and North America Regions
    Bourdin, Arnaud
    Criner, Gerard
    Devouassoux, Gilles
    Dransfield, Mark
    Halpin, David M. G.
    Han, MeiLan K.
    Jones, C. Elaine
    Kalhan, Ravi
    Lange, Peter
    Lettis, Sally
    Lipson, David A.
    Lomas, David A.
    Maria-Tome, Jose M. Echave-Sustaeta
    Martin, Neil
    Martinez, Fernando J.
    Quasny, Holly
    Sail, Lynda
    Siler, Thomas M.
    Singh, Dave
    Thomashow, Byron
    Watz, Henrik
    Wise, Robert
    Hanania, Nicola A.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (01): : 76 - 90
  • [28] Fluticasone Furoate/Umeclidinium/Vilanterol Initiation Following a COPD Exacerbation: Benefits of Prompt Initiation on COPD Outcomes
    David Mannino
    Kristi DiRocco
    Guillaume Germain
    François Laliberté
    Stephen G. Noorduyn
    Ana Urosevic
    Rosirene Paczkowski
    Advances in Therapy, 2024, 41 (12) : 4557 - 4580
  • [29] GENETIC VARIANTS DO NOT PREDICT ACUTE COPD EXACERBATIONS OR TREATMENT RESPONSE TO FLUTICASONE FUROATE/UMECLIDINIUM/VILANTEROL (FF/UMEC/VI) AND ITS COMPONENTS
    Hosking, Louise
    Yeo, Astrid
    Hoffman, Joshua
    Chiano, Mathias
    Fraser, Dana
    Ghosh, Soumitra
    Lipson, David
    Martin, Neil
    Condreay, Lynn
    Cox, Charles
    Stjean, Pamela
    CHEST, 2020, 158 (04) : 1800A - 1801A
  • [30] REAL-WORLD IMPACT OF TRIPLE THERAPY WITH FLUTICASONE FUROATE, UMECLIDINIUM, AND VILANTEROL ON ASTHMA CONTROL AMONG US PATIENTS WITH ASTHMA
    Bogart, Michael
    Germain, Guillaume
    Laliberte, Frakois
    Mahendran, Malena
    Duh, Mei S.
    CHEST, 2022, 162 (04) : 1930A - 1931A
12345